How Brookfield Infrastructure, Invitation Homes And Gilead Sciences Can Put Cash In Your Pocket

In this article:
How Brookfield Infrastructure, Invitation Homes And Gilead Sciences Can Put Cash In Your Pocket
How Brookfield Infrastructure, Invitation Homes And Gilead Sciences Can Put Cash In Your Pocket

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors. Brookfield Infrastructure Partners, Invitation Homes and Gilead Sciences have rewarded their shareholders for several decades and recently announced dividend increases. Furthermore, these companies offer high dividend yields of around 3-4%.

Check It Out:

  • This billion-dollar fund has invested in the next big real estate boom, here's how you can join for $10.
    This is a paid advertisement. Carefully consider the investment objectives, risks, charges and expenses of the Fundrise Flagship Fund before investing. This and other information can be found in the Fund's prospectus. Read them carefully before investing.

  • Your biggest returns may not come from the stock market. Invest the way colleges, pension funds, and the 1% do. Get started investing in commercial real estate today.

Brookfield Infrastructure Partners

Brookfield Infrastructure Partners L.P. (NYSE:BIP) is one of the largest owners and operators of critical global infrastructure networks, facilitating the movement and storage of energy, water, freight, passengers and data.

Brookfield Infrastructure Partners has raised its dividends every year since 2009. On Feb. 1, its Board of Directors announced its most recent dividend hike, increasing the quarterly dividend by 6% to $0.405 per share, equating to $1.62 annually. The current yield on the dividend stands at 4.78%.

The company's annual revenue (as of June 30) is $19.8 billion. For its most recent earnings release on Aug. 1, the company posted Q2 2024 revenues of $5.138 billion, beating the consensus estimate of $4.256 billion, as reported by Benzinga.

“We delivered strong second-quarter results driven by robust organic growth and the positive impact of several years of outsized capital deployment," said Sam Pollock, Chief Executive Officer of Brookfield Infrastructure Partners. "The outlook for growth is very favorable as the surge in AI adoption is generating substantial capital deployment opportunities across our data, electric utility and natural gas sectors."

Invitation Homes

Invitation Homes Inc. (NYSE:INVH) is the nation’s premier single-family home leasing and management company. It meets changing lifestyle demands by providing access to high-quality, updated homes with valued features such as proximity to jobs and access to good schools.

Invitation Homes has increased its dividends consecutively since 2017. According to the company's most recent dividend hike announcement on Dec. 8, 2023, it raised the quarterly dividend by 7.7% to $0.28 per share, equal to $1.12 annually. Currently, the company's dividend yield is 3.37%.

Invitation Homes' annual revenue (as of June 30) is $2.5 billion. According to the company’s Q2 2024 earnings report, released on July 24, it generated revenues of $653.45 million, slightly below the consensus estimate and an EPS of $0.47, matching expectations.

Check out this article by Benzinga, which analyzes Invitation Homes’ short interest.

Trending Now: A billion-dollar investment strategy with minimums as low as $10 — you can become part of the next big real estate boom today.
This is a paid advertisement. Carefully consider the investment objectives, risks, charges and expenses of the Fundrise Flagship Fund before investing. This and other information can be found in the Fund's prospectus. Read them carefully before investing.

Gilead Sciences

Gilead Sciences, Inc. (NYSE:GILD) develops and markets therapies to treat life-threatening infectious diseases. The core of its portfolio is focused on HIV and hepatitis B and C.

Gilead Sciences has consistently raised its dividends for the last eight years. On Feb. 6, in the company’s most recent dividend hike announcement, its Board of Directors raised its quarterly dividend by 2.7% to $0.77 or $3.08 annualized. The current dividend yield on the stock is 3.58%.

The company's annual revenue (as of June 30) stood at $27.8 billion. Gilead Sciences' most recent earnings release on Aug. 8 posted revenues of $6.95 billion and EPS of $2.01 for Q2 2024, both above consensus estimates.

Check out this article by Benzinga, which highlights two more Healthcare stocks delivering high-dividend yields.

Brookfield Infrastructure Partners, Invitation Homes and Gilead Sciences are good choices for investors seeking reliable passive income. Their dividend yields of around 3-4% and long history of consistent hikes make them attractive to income-focused investors.

Wondering if your investments can get you to a $5,000,000 nest egg? Speak to a financial advisor today. SmartAsset’s free tool matches you up with up to three vetted financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.

See Also:

This article How Brookfield Infrastructure, Invitation Homes And Gilead Sciences Can Put Cash In Your Pocket originally appeared on Benzinga.com

Advertisement